Dr. William G. Wierda on Role for Ibrutinib in Frontline CLL OncLive 1:38 8 years ago 274 Далее Скачать
Dr. Wierda on Factors to Consider in Frontline Management of CLL OncLive 2:07 8 years ago 233 Далее Скачать
Dr. William Wierda on RESONAT-2 Trial Predictions for Patients With CLL OncLive 1:20 9 years ago 237 Далее Скачать
Ibrutinib Plus Venetoclax as a Treatment Option for CLL Targeted Oncology 1:07 5 years ago 822 Далее Скачать
Dr. Wierda on Frontline Therapy for Older CLL Patients Compared to Younger OncLive 2:13 9 years ago 250 Далее Скачать
Dr. Wierda on Treatment Recommendations for Elderly Patients With CLL OncLive 1:43 10 years ago 220 Далее Скачать
What's New with CLL Treatments w/Top Expert | Dr. William Wierda, MD Anderson | The Patient Story The Patient Story 27:49 2 years ago 4 480 Далее Скачать
William Wierda | Ibrutinib and venetoclax combination for first-line CLL: CAPTIVATE phase II trial Lymphoma Hub 2:28 6 years ago 948 Далее Скачать
Dr. Wierda on Role of Rituximab Biosimilar in Evolving CLL Treatment Paradigm OncLive 1:39 5 years ago 249 Далее Скачать
Dr William Wierda talks about new treatment strategies in CLL Leukaemia Care 1:28 5 years ago 189 Далее Скачать
